From: Differential expression of anterior gradient gene AGR2 in prostate cancer
 | Stage III/IV patients | Mean AGR2 expression (SE) | P-value | Low AGR2 | High AGR2 | P-value |
---|---|---|---|---|---|---|
Total cases | 65 | 0.53 (0.057) | Â | 44 | 21 | Â |
Age at surgery | Â | Â | 0.7622 | Â | Â | 0.7631 |
   Median (range) | 66 (50-76) |  |  | 66 (50-76) | 65 (50-73) |  |
   Mean | 64.6 |  |  | 64.8 | 64.3 |  |
Gleason score | Â | Â | 0.0981 | Â | Â | 0.1613 |
   2-6 | 22 | 0.664 (0.104) |  | 12 | 10 |  |
   7-10 | 43 | 0.457 (0.066) |  | 32 | 11 |  |
pT stage | Â | Â | 0.4511 | Â | Â | 0.1113 |
   pT2-pT3a | 30 | 0.565 (0.087) |  | 17 | 13 |  |
   pT3b | 35 | 0.495 (0.076) |  | 27 | 8 |  |
Lymph node status | Â | Â | 0.1181 | Â | Â | 0.4803 |
   Positive | 11 | 0.353 (0.118) |  | 9 | 2 |  |
   Negative | 54 | 0.563 (0.064) |  | 35 | 19 |  |
Tumor margins | Â | Â | 0.9901 | Â | Â | 0.7943 |
   Positive | 35 | 0.536 (0.087) |  | 23 | 12 |  |
   Negative | 30 | 0.517 (0.072) |  | 21 | 9 |  |
Capsular invasion | Â | Â | 0.8051 | Â | Â | > 0.9993 |
   No invasion | 4 | 0.507 (0.174) |  | 3 | 1 |  |
   Invasion | 61 | 0.529 (0.060) |  | 41 | 20 |  |
PSA ng/mL | Â | Â | 0.4142 | Â | Â | 0.0891 |
   Median (range) | 11.9 (2.1-96.5) |  | 0.3531 |  |  | 0.0923 |
   Mean | 18.7 |  |  |  |  |  |
   < 10 | 25 | 0.607 (0.103) |  | 14 | 11 |  |
   ≥10 | 32 | 0.463 (0.073) |  | 25 | 7 |  |